Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LH | Common Stock | Sale | -$53.2K | -219 | -3.94% | $243.01 | 5.34K | Feb 7, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LH | Restricted Stock Unit | Award | $0 | +950 | +85.82% | $0.00 | 2.06K | Feb 7, 2023 | Common Stock | 950 | Direct | F2, F3, F4 | |
transaction | LH | Non-qualified Stock Options | Award | $0 | +3K | $0.00 | 3K | Feb 7, 2023 | Common Stock | 3K | $247.24 | Direct | F5, F6 |
Id | Content |
---|---|
F1 | Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. |
F2 | Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. |
F3 | The Restricted Stock Units vest in three equal annual installments beginning on February 7, 2024. |
F4 | This number reflects the aggregate number of Restricted Stock Units held by the reporting person. |
F5 | Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. |
F6 | The option vests in three equal annual installments beginning on the date reflected in this column. |